Next Generation to Identify Genetic Causes of Disease in Patients Participating in NICHD Clinical Protocols
| Status: | Completed |
|---|---|
| Conditions: | Other Indications, Women's Studies |
| Therapuetic Areas: | Other, Reproductive |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 3/29/2019 |
| Start Date: | June 16, 2011 |
Next Generation Sequencing to Identify Genetic Causes of Disease in Patients Participating in NICHD Clinical Protocols
Background:
- The purpose of this study is to identify changes in genes that cause human diseases. We
would like to obtain some of you or your child s DNA and test for changes in genes that may
contribute to a disease in you or your family.
Objective:
-To allow for exomic or genomic sequencing of NICHD patients or family members in order to
identify changes in genes that cause or contribute to a specific disease.
Eligibility:
- Children who are enrolled in an NICHD clinical study where the condition being studied
may have a genetic cause.
- Family members of a child who is eligible for this study.
Design:
- Children and family members will supply DNA samples. If the samples are already
available, no further DNA will be needed.
- If DNA is not available, samples of either blood or skin will be taken.
- We will use these samples with new DNA sequencing technology that looks at all the human
genes we know about. This is known as exome and genome sequencing.
- The purpose of this study is to identify changes in genes that cause human diseases. We
would like to obtain some of you or your child s DNA and test for changes in genes that may
contribute to a disease in you or your family.
Objective:
-To allow for exomic or genomic sequencing of NICHD patients or family members in order to
identify changes in genes that cause or contribute to a specific disease.
Eligibility:
- Children who are enrolled in an NICHD clinical study where the condition being studied
may have a genetic cause.
- Family members of a child who is eligible for this study.
Design:
- Children and family members will supply DNA samples. If the samples are already
available, no further DNA will be needed.
- If DNA is not available, samples of either blood or skin will be taken.
- We will use these samples with new DNA sequencing technology that looks at all the human
genes we know about. This is known as exome and genome sequencing.
Over the last few years advancements in DNA sequencing technology have progressed
significantly. It now is feasible and economical to sequence the exome (known genes) or the
entire genome. This technological advance can be applied to identifying genetic causes of
rare diseases where traditional methods such as mapping frequently failed due to insufficient
number of cases. These cases often present themselves in the context of other NICHD research
protocols, such as teaching protocols, where it would not be efficient for the individual
investigators to write a new protocol. It will also serve to standardize the consent document
across NICHD for investigators that do not include exomic/genomic sequencing in their own
protocol.
significantly. It now is feasible and economical to sequence the exome (known genes) or the
entire genome. This technological advance can be applied to identifying genetic causes of
rare diseases where traditional methods such as mapping frequently failed due to insufficient
number of cases. These cases often present themselves in the context of other NICHD research
protocols, such as teaching protocols, where it would not be efficient for the individual
investigators to write a new protocol. It will also serve to standardize the consent document
across NICHD for investigators that do not include exomic/genomic sequencing in their own
protocol.
- INCLUSION CRITERIA:
1. Proband s that are enrolled in an NICHD clinical protocol for which there is a
suspicion of an underlying genetic cause for a disease for which they are being
evaluated.
2. Family members of a proband who is eligible for this protocol.
EXCLUSION CRITERIA:
1. Normal volunteers unrelated to a proband with the disease of interest.
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Phone: 800-411-1222
Click here to add this to my saved trials
